U.S. Insurers Often Limit Biosimilar Coverage
Long-Term Biologic Use May Not Raise Melanoma Risk
Are ANAs More Prevalent in the U.S. Now Than in the Past?
WHO Expects HCQ Safety Findings by Mid-June
As Chinese Authorities Expand Use of Health Tracking Apps, Privacy Concerns Grow
Few Medicare Advantage Plans Cover Social Needs for Chronically Ill Patients
Hydroxychloroquine Tied to Increased Risk of Death in COVID-19 Patients
U.K. Healthcare Workers Begin COVID-19 HCQ Trial
Rheumatology Education Goes ViRL: New Online Courses Use Interactive Platforms to Engage Fellows
- 1
- 2
- 3
- …
- 616
- Next Page »